Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [916]
News [2620]
Articles [112]
Editorials [3]
Conferences [85]
elearning [27]
Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome...
Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The...
Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction ( Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The Netherlands )
3 Dec 2013
Cancer cells and the immune system: a natural story?
Prof. Laurence Zitvogel - INSERM, Institut Gustave Roussy, Villejuif, France
Cancer cells and the immune system: a natural story? ( Prof. Laurence Zitvogel - INSERM, Institut Gustave Roussy, Villejuif, France )
3 Dec 2013
Why are Immuno-Oncology compounds different?
Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain
Why are Immuno-Oncology compounds different? ( Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain )
3 Dec 2013
Immuno-Oncology: a concept or already a reality?
Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK
Immuno-Oncology: a concept or already a reality? ( Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK )
3 Dec 2013
Prevention of colorectal and lung cancer subtypes with aspirin
Dr Andrea De Censi - E.O. Ospedali Galliera, Genova, Italy
Prevention of colorectal and lung cancer subtypes with aspirin ( Dr Andrea De Censi - E.O. Ospedali Galliera, Genova, Italy )
27 Nov 2013
Contribution of the Peruvian Commission against tobacco (COLAT PERU)
Dr Luis Pinillos - National Institute of Neoplastic Diseases (INEM), Lima, Peru
Contribution of the Peruvian Commission against tobacco (COLAT PERU) ( Dr Luis Pinillos - National Institute of Neoplastic Diseases (INEM), Lima, Peru )
22 Nov 2013
Comparing toxicity profiles for 72 hour infusional and conventional bleomycin...
Dr Jonathan Shamash - Barts Cancer Institute, London, UK
Comparing toxicity profiles for 72 hour infusional and conventional bleomycin in testicular cancer ( Dr Jonathan Shamash - Barts Cancer Institute, London, UK )
15 Nov 2013
UK fight for tobacco control
Prof Linda Bauld - University of Stirling, Stirling, UK
UK fight for tobacco control ( Prof Linda Bauld - University of Stirling, Stirling, UK )
14 Nov 2013
Engineering of polymeric nanoparticles for medical applications
Dr Omid Farokhzad - Harvard Medical School, Boston, USA
Engineering of polymeric nanoparticles for medical applications ( Dr Omid Farokhzad - Harvard Medical School, Boston, USA )
14 Nov 2013
Editor’s Choice - ecancermedicalscience November 2013
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Editor’s Choice - ecancermedicalscience November 2013 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
14 Nov 2013
The immune microenvironment as an anti-cancer therapeutic strategy
Dr Lisa Coussens - Oregon Science & Health University, USA
The immune microenvironment as an anti-cancer therapeutic strategy ( Dr Lisa Coussens - Oregon Science & Health University, USA )
12 Nov 2013
Choosing the right treatment for each patient: The emergence of personalised...
Dr Frances Shepherd - Princess Margaret Hospital and the University of Toronto...
Choosing the right treatment for each patient: The emergence of personalised healthcare in non-small cell lung cancer ( Dr Frances Shepherd - Princess Margaret Hospital and the University of Toronto, Canada )
8 Nov 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation